Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now OTC Markets OTCQB - Delayed Quote • USD Sigyn Therapeutics, Inc. (SIGY) Follow Compare 4.1200 0.0000 (0.00%) At close: February 21 at 3:00:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now MIAMI, Feb. 19, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 79th Emerging Growth Conference on February 18 & 19, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting com Sigyn Therapeutics to Present at Tomorrow's Emerging Growth Conference The Company Invites Investors, Industry Executives, and Analysts to Attend Its Real-time, Interactive Presentation SAN DIEGO, CA - February 18, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of n... Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Small Cap Growth Virtual Investor Conference, held February 6th are now available for online viewing. REGISTER NOW AT: https://bit.ly/3Eu7J6w The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts ma Sigyn Therapeutics to Present at Tomorrow’s Small Cap Growth Virtual Investor Conference Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.comSAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a developer of next-generation blood purification technologies to treat cancer and life-threatening infectious disease disorders, today announced that Jim Joyce, the Company’s CEO will present live at tomorrow’s Small Cap Growth Virtual Investor Co Small Cap Growth Virtual Investor Conference Agenda Announced for February 6th Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Small Cap Growth Virtual Investor Conference to be held February 6th. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://bit.ly/3PUIzQM It is recommended that investors pre-register and ru Sigyn Therapeutics Announces the Appointment of Michael Ryan to Its Board of Directors SAN DIEGO, CA - January 29, 2025 (NEWMEDIAWIRE) - Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of blood purification technologies to treat life-threatening conditions, today announced the appointment of Michael Ryan ... Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now MIAMI, Oct. 29, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 76th Emerging Growth Conference on October 30 & 31, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting comp Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now MIAMI, Aug. 20, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 74th Emerging Growth Conference on August 21 – 22, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compa OTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand Viewing Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.comNEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the presentations from the August 1st OTCQB Venture Virtual Investor Conference are now available for on-demand viewing. REGISTER OR LOGIN TO VIEW THE PRESENTATIONS AT: https://bit.ly/4fvVmF8 The company presentations will be available 24/7 for 90 days. Investors, advisors, and OTCQB Venture Virtual Investor Conference Agenda Announced for August 1st Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, July 30, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the OTCQB Venture Virtual Investor Conference to be held on August 1st, 2024. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://bit.ly/4fiX1xA It is recommended that investors pre-register an Sigyn Therapeutics Reports First Quarter 2024 Financial Results SAN DIEGO, CA - (NewMediaWire) - May 15, 2024 - Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024.During the... Presenting on the Emerging Growth Conference 70 Day 2 on May 9 Register Now MIAMI, May 08, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 70th Emerging Growth Conference on May 8 & 9, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies t Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections" SAN DIEGO, CA - (NewMediaWire) - May 07, 2024 - Sigyn Therapeutics, Inc. ("Sigyn Therapeutics", "Sigyn" or the "Company") (OTCQB: "SIGY"), a development-stage medical technology company, announced today that it has published an article entitled: "Sig... Sigyn Therapeutics™ to Present at Tomorrow’s Emerging Growth Conference Live Online Presentation Scheduled at 12 pm EST on March 6th SAN DIEGO, CA, March 05, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn Therapeutics” or the “Company”) (OTCQB:”SIGY”), a development-stage medical technology company, announced today that its CEO, Jim Joyce will give a live presentation at tomorrow’s Emerging Growth Conference. The presentation is scheduled to begin at 12 pm eastern standard time. The presentation will include an update on Sigyn TherapyT Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now MIAMI, March 05, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 68th Emerging Growth Conference on March 6 & 7, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani Performance Overview Trailing total returns as of 2/21/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return SIGY S&P 500 YTD +30.79% +2.24% 1-Year -17.60% +20.70% 3-Year -74.25% +38.27%